Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,019 | 5,122 | 0 | 0 | 0 |
| Receivables | 84 | 114 | 0 | 0 | 0 |
| TOTAL | $4,478 | $5,799 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 137 | 151 | 0 | 0 | 0 |
| TOTAL | $137 | $151 | $N/A | $N/A | $N/A |
| Total Assets | $4,615 | $5,950 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 250 | 250 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 149 | 384 | 0 | 0 | 0 |
| Accrued Expenses | 181 | 389 | 0 | 0 | 0 |
| Other current liabilities | 78 | 71 | 0 | 0 | 0 |
| TOTAL | $717 | $1,178 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 81 | 96 | 0 | 0 | 0 |
| TOTAL | $81 | $96 | $N/A | $N/A | $N/A |
| Total Liabilities | $798 | $1,275 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 718 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 0 | 0 |
| Retained earnings | -6,773 | -5,705 | 0 | 0 | 0 |
| TOTAL | $3,816 | $4,676 | $0 | $0 | $0 |
| Total Liabilities And Equity | $4,615 | $5,950 | $0 | $0 | $0 |